Intrexon | XON - Credores Comerciais





Credores Comerciais Alterar Data
Agenus USD 58.98M 12.1M 2026-06
Alaunos Therapeutics USD 732K 332K 2026-06
Amgen USD 20.83B 17.97B 2026-09
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
AstraZeneca USD 23.57B 679M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Heron Therapeutics USD 11.64M 2.67M 2026-06
Incyte USD 235.37M 1.16B 2026-09
Intrexon USD 4.85M 3.12M 2024-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Ligand Pharmaceuticals USD 4.1M 5.31M 2026-09
MacroGenics USD 3.44M 845K 2026-06
MannKind USD 14.38M 3.34M 2026-09
Merck USD 5.03B 1.2B 2026-09
Novartis USD 4.24B 15M 2026-09
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Thermo Fisher Scientific USD 3.09B 181M 2026-09
Veracyte USD 9.71M 1.69M 2026-09
Xencor USD 6.65M 6M 2026-09